Physician profile
Will D Heise
NPI 1962840504
$3,256.49
in general payments reported to CMS, 2019-2025
17 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $905 · 2020: $210 · 2021: $14.24 · 2022: $150 · 2023: $565 · 2024: $384 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $775.62 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $740.96 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $392.03 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $306.95 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $213.26 | 2019-2025 | Wegovy, Saxenda, Rybelsus |
| Allergan, INC. | $202.97 | 2019-2020 | |
| Pfizer INC. | $117.93 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.04 | 2024-2025 | Jardiance |
| Exact Sciences Corporation | $82.92 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $69.62 | 2019-2025 | Otezla, Repatha |
| Halozyme INC | $57.90 | 2023 | |
| Lundbeck LLC | $56.47 | 2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $54.90 | 2019-2020 | |
| Abbott Laboratories | $33.64 | 2024 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $29.28 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $23.68 | 2023 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Will Heise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.